Calibrate has named Rob MacNaughton as its new CEO, the weight loss telehealth company announced Thursday.
MacNaughton replaces founder and CEO Isabelle Kenyon, who stepped down in October along with the company's chief financial officer, Dave Fielding.
Related article: Calibrate CEO is stepping down from role at weight loss company
MacNaughton was previously venture chair for New York City-based Redesign Health, a company that helps create and invests in healthcare startups. It was involved in Calibrate's launch. He also served as CEO of Curve Health, a support platform for skilled-nursing facilities, and NurseGrid, a scheduling and online education app for nurses.
Calibrate, a provider of glucagon-like peptide-1 agonists, or GLP-1s, entered a strategic partnership with OptumRx in August.
In October, Calibrate, underwent an ownership restructuring supported by a financial commitment from Madryn Asset Management and other investors. The company also cut 18% of its employees last April.
Last year, several weight loss drug providers were impacted when insurers declined to provide coverage for the medications, as well as GLP-1 shortages, including Wegovy, Ozempic and Trulicity.
